JHS Svendgaard Laboratories
Jhs Svendgaard Laboratories Performance
Day Range
- Low 24.15
- High 25.75
52 Week Range
- Low 13.42
- High 28.20
- Open Price24.15
- Previous Close24.55
- Volume339159
Start SIP in JHS Svendgaard Laboratories
Start SIPJhs Svendgaard Laboratories Investment Rating
-
Master Rating:
-
Jhs Svendgaard Labs. has an operating revenue of Rs. 88.80 Cr. on a trailing 12-month basis. An annual revenue growth of 16% is outstanding, Pre-tax margin of -23% needs improvement, ROE of -8% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 5% and 23% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around -7% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 13 which is a POOR score indicating inconsistency in earnings, a RS Rating of 61 which is FAIR indicating the recent price performance, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 155 indicates it belongs to a poor industry group of Cosmetics/Personal Care and a Master Score of D is close to being the worst. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
Indicator | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
---|---|---|---|---|---|---|---|
Oper Rev Qtr Cr | 19 | 15 | 21 | 21 | 21 | 19 | 17 |
Operating Expenses Qtr Cr | 19 | 17 | 24 | 23 | 23 | 20 | 18 |
Operating Profit Qtr Cr | 0 | -2 | -3 | -2 | -2 | -1 | 0 |
Depreciation Qtr Cr | 1 | 1 | 2 | 1 | 1 | 1 | 1 |
Interest Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Qtr Cr | 0 | 0 | -7 | 0 | 0 | 2 | 4 |
Net Profit Qtr Cr | -1 | -2 | -9 | -2 | -1 | -3 | -4 |
Jhs Svendgaard Laboratories Technicals
EMA & SMA

- Bullish Moving Average
- ___
- 16
- Bearish Moving Average
- ___
- 0
- 20 Day
- ₹24.88
- 50 Day
- ₹23.97
- 100 Day
- ₹23.11
- 200 Day
- ₹22.23
- 20 Day
- ₹25.13
- 50 Day
- ₹23.30
- 100 Day
- ₹23.36
- 200 Day
- ₹20.68
Jhs Svendgaard Laboratories Resistance and Support
Resistance | |
---|---|
First Resistance | 24.92 |
Second Resistance | 25.28 |
Third Resistance | 25.72 |
RSI | 49.74 |
MFI | 41.23 |
MACD Single Line | 0.80 |
MACD | 0.54 |
Support | |
---|---|
First Resistance | 24.12 |
Second Resistance | 23.68 |
Third Resistance | 23.32 |
Jhs Svendgaard Laboratories Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 197,667 | 13,415,659 | 67.87 |
Week | 286,819 | 18,387,940 | 64.11 |
1 Month | 341,593 | 22,705,671 | 66.47 |
6 Month | 274,990 | 20,162,292 | 73.32 |
Jhs Svendgaard Laboratories Result Highlights
JHS Svendgaard Laboratories Synopsis
NSE-Cosmetics/Personal Care
Jhs Svendgaard Labor belongs to the Industry of Personal Care. Company’s Total Operating Revenue is Rs. 81.92 Cr. and Equity Capital is Rs. 64.90 Cr. for the Year ended 31/03/2023. JHS Svendgaard Laboratories Ltd. is a Public Limited Listed company incorporated on 08/10/2004 and has its registered office in the State of Himachal Pradesh, India. Company’s Corporate Identification Number(CIN) is L74110HP2004PLC027558 and registration number is 027558.Market Cap | 202 |
Sales | 76 |
Shares in Float | 4.86 |
No of funds | |
Yield |
Book Value | 0.91 |
U/D Vol ratio | 1.3 |
LTDebt / Equity | |
Alpha | 0.02 |
Beta | 1.4 |
JHS Svendgaard Laboratories
Owner Name | Sep-23 | Jun-23 | Mar-23 | Dec-22 |
---|---|---|---|---|
Promoters | 37.73% | 42.23% | 42.23% | 42.23% |
Mutual Funds | ||||
Insurance Companies | ||||
Foreign Portfolio Investors | ||||
Financial Institutions/ Banks | ||||
Individual Investors | 39.85% | 46.36% | 48.49% | 47.29% |
Others | 22.42% | 11.41% | 9.28% | 10.48% |
JHS Svendgaard Laboratories Management
Name | Designation |
---|---|
Mr. Vanamali Polavaram | Chairman & Non-Exe.Director |
Mr. Nikhil Nanda | Managing Director |
Mr. Mukul Pathak | Independent Director |
Mrs. Rohina Sanjay Sangtani | Independent Director |
Mr. Rajagopal Chakravarthi Venkateish | Independent Director |
Mr. Kapil Minocha | Independent Director |
Mrs. Balbir Verma | Independent Director |
Mr. Nikhil Kishorchandra Vora | Nominee Director |
Jhs Svendgaard Laboratories Forecast
Price Estimates
Jhs Svendgaard Laboratories Corporate Action
Date | Purpose | Remarks |
---|---|---|
2024-02-21 | John Hancock Income Securities Trust Annual General Meeting for 2023 | |
2023-12-22 | John Hancock Income Securities Trust Annual Report for 2023 | |
2023-11-07 | Quarterly Results | |
2023-08-14 | Quarterly Results | |
2023-06-29 | John Hancock Income Securities Trust Second Quarter Earnings Results for 2023 |
Date | Purpose | Remarks |
---|---|---|
2023-09-11 | DEFAULT | |
2022-06-13 | DEFAULT | |
2021-09-13 | DEFAULT | |
2021-06-11 | DEFAULT |
JHS Svendgaard Laboratories FAQs
What is Share Price of JHS Svendgaard Laboratories ?
JHS Svendgaard Laboratories share price is ₹25 As on 06 December, 2023 | 17:24
What is the Market Cap of JHS Svendgaard Laboratories ?
The Market Cap of JHS Svendgaard Laboratories is ₹201.9 Cr As on 06 December, 2023 | 17:24
What is the P/E ratio of JHS Svendgaard Laboratories ?
The P/E ratio of JHS Svendgaard Laboratories is -13.6 As on 06 December, 2023 | 17:24
What is the PB ratio of JHS Svendgaard Laboratories ?
The PB ratio of JHS Svendgaard Laboratories is 1.1 As on 06 December, 2023 | 17:24